Enhancing magnetic resonance imaging tumor detection with fluorescence intensity and lifetime imaging

  • Erten A
  • Hall D
  • Hoh C
  • et al.
6Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Early detection is important for many solid cancers but the images provided by ultrasound, magnetic resonance imaging (MRI), and computed tomography applied alone or together, are often not sufficient for decisive early screeningdiagnosis. We demonstrate that MRI augmented with fluorescence intensity (FI) substantially improves detection. Early stage murine pancreatic tumors that could not be identified by blinded, skilled observers using MRI alone, were easily identified with MRI along with FI images acquired with photomultiplier tube detection and offset laser scanning. Moreover, we show that fluorescence lifetime (FLT) imaging enables positive identification of the labeling fluorophore and discriminates it from surrounding tissue autofluorescence. Our data suggest combined-modality imaging with MRI, FI, and FLT can be used to screen and diagnose early tumors. © 2010 Society of Photo-Optical Instrumentation Engineers.

Cite

CITATION STYLE

APA

Erten, A., Hall, D., Hoh, C., Tran Cao, H. S., Kaushal, S., Esener, S., … Makale, M. (2010). Enhancing magnetic resonance imaging tumor detection with fluorescence intensity and lifetime imaging. Journal of Biomedical Optics, 15(6), 066012. https://doi.org/10.1117/1.3509111

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free